UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549

                                    FORM 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(D) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

        DATE OF REPORT  (DATE OF EARLIEST EVENT REPORTED):  MAY 13, 2005



                        N-VIRO INTERNATIONAL CORPORATION
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)


                       DELAWARE           0-21802        34-1741211
                   (STATE OR OTHER   (COMMISSION FILE   (IRS EMPLOYER
                   JURISDICTION OF         NUMBER)      IDENTIFICATION
                  INCORPORATION OR                            NO.)
                    ORGANIZATION)


            3450 W. CENTRAL AVENUE, SUITE 328 TOLEDO, OHIO     43606
             (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)         (ZIP CODE)

      REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:    (419) 535-6374

Check  the  appropriate  box  below  if  the  Form  8-K  filing  is  intended to
simultaneously  satisfy the filing obligation of the registrant under any of the
following  provisions  (see  General  Instruction  A.2.  below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act  (17  CFR  240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act  (17  CFR  240.13e-4(c))





Item 5.02 - Departure of Directors or Principal Officers; Election of Directors;
Appointment  of  Principal  Officers

     (b)     On  May  13,  2005,  Christopher  J.  Anderson,  a member of N-Viro
International  Corporation's  (the  "Company")  Board  of Directors as a Class I
director,  notified  the  Company  of his intention to resign from the Company's
Board  of  Directors,  effective  immediately,  due  to  personal  reasons.  Mr.
Anderson  was  scheduled  to stand for re-election to the Board at the Company's
2005  Annual Meeting of Stockholders to be held on June 30, 2005.  The Board did
not  replace  Mr.  Anderson  at  this  time.


Item 5.03 - Amendments to Articles of Incorporation or By-Laws; Change in Fiscal
Year

     (a)     On  May  13,  2005,  the  Company's  Board of Directors amended the
Amended  and  Restated  By-Laws  of  the Company, (the "By-Laws"), to change the
requirement  for the election of directors from a plurality to a majority of the
votes  cast.  This new language is included as Exhibit 99.1 to this Form 8-K.  A
copy  of the Company's Amended and Restated By-Laws, as amended on May 13, 2005,
was  attached  as  Exhibit  3.3 to the Company's Form 10-QSB filed May 16, 2005.

Item  8.01  -  Other  Events

     As  announced  by  the  Company  in its Form 10-QSB filed May 16, 2005, the
Company's  Board  of  Directors  postponed  the  Annual  Meeting of Stockholders
originally  scheduled  for  Thursday,  May  19,  2005, until June 30, 2005.  The
location of the Annual Meeting has not changed and will be in the Garden Room of
the  Toledo Club, 235 14th Street, Toledo, Ohio at 10:00 a.m.  The Company filed
a  Notice  of  Postponement  on  May  11,  2005  with the SEC in a Schedule 14A,
Definitive  Additional  Materials,  and  was sent to all stockholders on May 13,
2005.  The  Company will file a revised definitive proxy statement on an Amended
Schedule  14A,  which  will  be  sent  to  all  stockholders.

Item  9.01  -  Financial  Statements  and  Exhibits

(c)     Exhibits

     Exhibit  No.     Description
     99.1          Text  of  amendment  to  the  Amended and Restated By-Laws of
N-Viro  International  Corporation.



                                    SIGNATURE

     Pursuant  to  the  requirements of the Securities Exchange Act of 1934, the
Company  has  duly  caused  this  report  to  be  signed  on  its  behalf by the
undersigned  hereunto  duly  authorized.

                        N-VIRO INTERNATIONAL CORPORATION


Dated:          May  19,  2005               By:       /s/  James K. McHugh
                --------------                         ----------------------
                                                       James  K.  McHugh
                                                       Chief  Financial  Officer